Kolexia
Merrouche Yacine Oncologie médicale
Merrouche Yacine
Oncologie médicale
Institut Godinot
Reims, France
68 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes COVID-19 Tumeurs du sein triple-négatives Carcinome épidermoïde Tumeurs de l'ovaire Tumeurs du poumon Tumeurs du côlon Tumeurs de la prostate

Collaborateurs

Voir plus
Magné Nicolas
Magné Nicolas
Scp Drs Franck Dudouet Et Autres, Oncorad Garonne, Toulouse, France
Chargari Cyrus
Chargari Cyrus
Hôpital Pitie Salpetriere, Paris, France
Auberdiac Pierre
Auberdiac Pierre
Hôpital Jacques Puel - Bourran, Rodez, France
Garbar Christian
Garbar Christian
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France

Industries

Voir plus
Pfizer
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.
Breast cancer research : BCR   15 février 2024
Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6C monocytes and differentiation to pro-angiogenic myeloid cells.
Nature communications   14 septembre 2022
One-year COVID-19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross-sectional comprehensive study (ONCOCARE-COV).
Cancer medicine   20 mai 2022
EPITHERM: A Prospective Multicentric Evaluation of the Rate of Incidence of Hypothyroidism After Supraclavicular Irradiation for Breast Cancer
Essai Clinique (Institut Jean-Godinot)   30 août 2021
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France.
ESMO open   17 avril 2021
Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV Study.
The oncologist   11 novembre 2020
The Interleukin-17 Family of Cytokines in Breast Cancer.
International journal of molecular sciences   04 décembre 2018
Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape.
Cancer management and research   04 mai 2018
IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.
Oncotarget   29 janvier 2018
HBV infection: Screening and treatment for oncology patients.
Bulletin du cancer   22 octobre 2017